Page last updated: 2024-10-24

chlorambucil and Group A Strep Infection

chlorambucil has been researched along with Group A Strep Infection in 1 studies

Chlorambucil: A nitrogen mustard alkylating agent used as antineoplastic for chronic lymphocytic leukemia, Hodgkin's disease, and others. Although it is less toxic than most other nitrogen mustards, it has been listed as a known carcinogen in the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (Merck Index, 11th ed)
chlorambucil : A monocarboxylic acid that is butanoic acid substituted at position 4 by a 4-[bis(2-chloroethyl)amino]phenyl group. A chemotherapy drug that can be used in combination with the antibody obinutuzumab for the treatment of chronic lymphocytic leukemia.

Research Excerpts

ExcerptRelevanceReference
"Pyomyositis has become an increasingly recognized disease in temperate climates."2.37Pyomyositis in a patient with progressive systemic sclerosis. Case report and review of the literature. ( Baum, S; Minor, RL; Schulze-Delrieu, KS, 1988)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Minor, RL1
Baum, S1
Schulze-Delrieu, KS1

Reviews

1 review available for chlorambucil and Group A Strep Infection

ArticleYear
Pyomyositis in a patient with progressive systemic sclerosis. Case report and review of the literature.
    Archives of internal medicine, 1988, Volume: 148, Issue:6

    Topics: Chlorambucil; Female; Humans; Middle Aged; Myositis; Scleroderma, Systemic; Streptococcal Infections

1988